You are here: Home » Companies » News
Business Standard

Dr Reddy's Q4 profit falls 19 % on US headwinds, revenue drops to Rs 14 bn

Revenue from its generics business in Europe plunged 17 per cent largely due to supply disruptions

Reuters 

Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 19 percent drop in quarterly net profit on Tuesday, missing analysts' estimates, pulled down by headwinds in the US market. The company's net profit, for the quarter ended March 31, came in at 2.72 billion rupees ($39.98 million), compared with 3.38 billion rupees a year earlier, the company said https://www.bseindia.com/xml-data/corpfiling/AttachLive/280bdd33-dda4-4c5f-8624-b01b7efaeb68.pdf. Nineteen analysts on average expected a net profit of 3.59 billion rupees, according to Thomson Reuters ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, May 22 2018. 15:25 IST
RECOMMENDED FOR YOU